Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

By E. Mamessier, Aude Sylvain, Marie‐Laure Thibult, G. Houvenaeghel, J. Jacquemier, R. Castellano, A. Gonçalves, P. André, F. Romagné, G. Thibault and 5 more. Journal of Clinical Investigation, 2011

613 citations recorded by the source corpus.

Subfields: Immunology

View Paper: https://www.semanticscholar.org/paper/c4154d8d7139a6c52e5ec876f99d493deb3311a4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. É. Vivier

Citations in the corpus

• Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells (2018, background): “Our data for NKG2A expression are consistent with earlier reports on tumor-infiltrating NK and T cells in melanoma and breast and cervical cancers (Mamessier et al., 2011; Sheu et al., 2005).”